Most organizations suffer from process imbalance, with too much structure in some areas and too little in others. Here’s how ...

Over the years, I’ve seen firsthand how evolving standards and increasing demands for precision are reshaping the way the ...

Decades of selling PFAS left the iconic American manufacturer mired in legal liabilities. A new CEO is hoping to spark a ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Bridge loans, often called bridge financing or bridging loans, serve as short-term financial ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Vikki Velasquez is a researcher and writer who has managed, coordinated, and ...

Twenty years after the introduction of the theory, we revisit what it does—and doesn’t—explain. by Clayton M. Christensen, Michael E. Raynor and Rory McDonald Please enjoy this HBR Classic. Clayton M.

If you could save lives by producing vaccines in transgenic bananas, would you? In the debate over large-scale commercialization and use of GMOs, where should we draw the line? Vaccines Tobacco ...